We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Healgen

Healgen Scientific develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. The Healgen... read more Featured Products: More products

Download Mobile App





Healgen Scientific Exhibits Broad Diagnostic Portfolio at ADLM 2026

By LabMedica International staff writers
Posted on 28 Jul 2026

At ADLM 2026, Healgen Scientific is showcasing a broad diagnostic portfolio covering infectious diseases, toxicology, women’s health, urinalysis, fluorescent immunoassays, point-of-care testing, biochemistry, and animal health. More...

The company is presenting these solutions during the Clinical Lab Expo, held July 26–30 at the Anaheim Convention Center in California.

A key focus of the company’s exhibit is infectious disease testing. Healgen is showcasing rapid tests for respiratory infections, sexually transmitted infections, blood-borne diseases, and tropical and vector-borne conditions, including malaria, dengue, and Zika. The portfolio is designed to support testing across laboratories, clinics, and point-of-care environments.

In toxicology, Healgen is presenting urine and oral-fluid drug tests alongside harm-reduction products. The company is also highlighting the HealSnap mobile application, which supports its toxicology testing solutions and is intended to extend digital capabilities around rapid test workflows.

The company’s women’s health portfolio includes tests for pregnancy, ovulation, menopause, urinary tract infections, and vaginal pH. Healgen is additionally featuring multiparameter urinalysis strips covering clinical chemistry indicators such as glucose, ketones, protein, nitrite, and microalbumin.

Healgen is also showcasing benchtop and handheld fluorescent immunoassay platforms designed for testing across multiple clinical areas. Available applications include anemia, cardiovascular disease, diabetes, fertility, kidney injury, respiratory disease, thyroid disorders, and toxicology.

For laboratories seeking instrument-based and automated workflows, the exhibit includes the GeneStream real-time PCR system, the CLIA-go Pro platform, chemiluminescence technologies, automatic biochemistry analyzers, and dry chemistry systems. These solutions are intended to address testing needs ranging from decentralized clinical settings to professional and high-throughput laboratories.

The company is additionally presenting animal health solutions for companion and food animals. The portfolio includes rapid tests, molecular diagnostic technologies, and biochemistry systems designed to support veterinary testing across different care and production environments.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Thyroid Test
Anti-Thyroid EIA Test
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.